170 related articles for article (PubMed ID: 24385691)
1. Evaluation of miR-122-regulated suicide gene therapy for hepatocellular carcinoma in an orthotopic mouse model.
Wang G; Dong X; Tian W; Lu Y; Hu J; Liu Y; Yuchi J; Wu X
Chin J Cancer Res; 2013 Dec; 25(6):646-55. PubMed ID: 24385691
[TBL] [Abstract][Full Text] [Related]
2. miR-122a-Regulated Expression of a Suicide Gene Prevents Hepatotoxicity Without Altering Antitumor Effects in Suicide Gene Therapy.
Suzuki T; Sakurai F; Nakamura SI; Kouyama E; Kawabata K; Kondoh M; Yagi K; Mizuguchi H
Mol Ther; 2008 Oct; 16(10):1719-1726. PubMed ID: 28189004
[TBL] [Abstract][Full Text] [Related]
3. miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapy.
Suzuki T; Sakurai F; Nakamura S; Kouyama E; Kawabata K; Kondoh M; Yagi K; Mizuguchi H
Mol Ther; 2008 Oct; 16(10):1719-26. PubMed ID: 18665157
[TBL] [Abstract][Full Text] [Related]
4. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
[TBL] [Abstract][Full Text] [Related]
5. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
6. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma.
Tsuchiyama T; Kaneko S; Nakamoto Y; Sakai Y; Honda M; Mukaida N; Kobayashi K
Cancer Gene Ther; 2003 Apr; 10(4):260-9. PubMed ID: 12679798
[TBL] [Abstract][Full Text] [Related]
9. Regulation of HSVtk gene by endogenous microRNA-122a in liver cell lines as suicide gene therapy.
Ghanbari M; Saberfar E; Goodarzi Z; Lashini H; Ghanbari S; Karamimanesh M; Baesi K
Gastroenterol Hepatol Bed Bench; 2017; 10(3):202-207. PubMed ID: 29118936
[TBL] [Abstract][Full Text] [Related]
10. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated suicide-gene therapy in an orthotopic murine bladder tumor model.
Cheon J; Moon DG; Cho HY; Park HS; Kim JJ; Gardner TA; Kao C
Int J Urol; 2002 May; 9(5):261-7. PubMed ID: 12060439
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
Wang ZX; Bian HB; Yang JS; De W; Ji XH
Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
[TBL] [Abstract][Full Text] [Related]
13. Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control.
Mathis JM; Williams BJ; Sibley DA; Carroll JL; Li J; Odaka Y; Barlow S; Nathan CO; Li BD; DeBenedetti A
J Gene Med; 2006 Sep; 8(9):1105-20. PubMed ID: 16802401
[TBL] [Abstract][Full Text] [Related]
14. Midkine promoter-based adenoviral suicide gene therapy to midkine-positive pediatric tumor.
Adachi Y; Matsubara S; Muramatsu T; Curiel DT; Reynolds PN
J Pediatr Surg; 2002 Apr; 37(4):588-92. PubMed ID: 11912516
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus vector-mediated herpes simplex virus-thymidine kinase gene/ganciclovir system exhibits anti-tumor effects in an orthotopic hepatocellular carcinoma model.
Zhu R; Chen D; Lin D; Lu F; Yin J; Li N
Pharmazie; 2014 Jul; 69(7):547-52. PubMed ID: 25073402
[TBL] [Abstract][Full Text] [Related]
16. Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models.
Zheng FQ; Xu Y; Yang RJ; Wu B; Tan XH; Qin YD; Zhang QW
Acta Pharmacol Sin; 2009 May; 30(5):617-27. PubMed ID: 19363518
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase.
Mizuguchi H; Hayakawa T
Cancer Gene Ther; 2002 Mar; 9(3):236-42. PubMed ID: 11896439
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated suicide-gene therapy using the herpes simplex virus thymidine kinase gene in cell and animal models of human prostate cancer: changes in tumour cell proliferative activity.
Cheon J; Kim HK; Moon DG; Yoon DK; Cho JH; Koh SK
BJU Int; 2000 Apr; 85(6):759-66. PubMed ID: 10759680
[TBL] [Abstract][Full Text] [Related]
19. Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
Sakai Y; Kaneko S; Nakamoto Y; Kagaya T; Mukaida N; Kobayashi K
Cancer Gene Ther; 2001 Oct; 8(10):695-704. PubMed ID: 11687892
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of HSV-tk gene therapy in a rat model of chemically induced hepatocellular carcinoma by intratumoral and intrahepatic artery routes.
Gerolami R; Cardoso J; Lewin M; Bralet MP; Sa Cunha A; Clément O; Bréchot C; Tran PL
Cancer Res; 2000 Feb; 60(4):993-1001. PubMed ID: 10706115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]